02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
On January 12, 2020, the United States Department of Labor ("USDOL") Wage and Hour Division announce...
Read More >
While New York employers are rushing to comply with the new amendments to New York State’s anti-dis...
Read More >
On July 3, 2019, the National Labor Relations Board (NLRB) modified the legal framework in which an ...
Read More >
Companies doing business with the federal government must comply with a litany of complex laws and r...
Read More >
Sponsorship Brochure for That 401(k) Conference at Busch Stadium in St. Louis, MO on May 8, 2020...B...
Read More >
Perhaps the most shocking aspect of employment-related cases from the 2018-2019 Supreme Court term t...
Read More >